ACTRN12611001025921招募中2 期
A Phase II, Randomised, Open, Controlled Trial of the Effects of Active Video Games on Physical Activity Levels for Sedentary People with Type 2 Diabetes Mellitus
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Prevention
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 75 Years（—）
- 性别
- All
入选标准
- •a)Participant is capable of giving informed consent;
- •b)Aged >= 18 years and < 75 years;
- •c)Diagnosed with stable type 2 diabetes mellitus;
- •d)Are sedentary (sedentary behaviour for this study includes activities that do not involve energy expenditure greater than 1.0-2.9 metabolic equivalent units (METs). Potential participants are eligible if they have NOT participated in any brisk walking or more energetic activity in the previous month”)
- •e)Reside in the Ipswich Area;
- •f)Can attend exercise classes during working hours
- •g)Has GP advice that they are well enough to participate in moderate-to-vigorous physical activity
排除标准
- •a)Receiving insulin therapy (due to increased risk of hypoglycaemia);
- •b)Participating in physical activity > = 2 times per week for at least 20 minutes per session or in a formal physical activity programme;
- •c)Participating in another study;
- •d)Has active video games at home;
- •e)Reports changes in oral hypoglycaemic medications during the previous 2 months;
- •f)Reports a change of > = 5% of body weight during previous 2 months;
- •g)Has serum creatinine > = 200 micromol/l;
- •h)Has proteinuria > 1g/ 24h;
- •(i)Has blood pressure > 160/95 mmHg;
- •(j) Has other medical conditions including injuries making participation inadvisable;
- •(k) Given GP advice not to participate
研究者
相似试验
进行中（未招募）
1 期
A Phase 2 Trial of BMS-986218 or BMS-986218/Nivolumab in Combination with Docetaxel in Metastatic Castration-resistant Prostate CancerMetastatic Castration-resistant Prostate CancerMedDRA version: 21.1Level: PTClassification code 10036909Term: Prostate cancer metastaticSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2021-003990-74-GRBristol-Myers Squibb International Corporation204
进行中（未招募）
不适用
An open, randomized, controlled, phase II study to evaluate the safety and immunogenicity of GlaxoSmithKline Biologicals’ 11-valent pneumococcal conjugate vaccine, when administered intramuscularly as a 3, 5, 12 month vaccination schedule, as part of a staggered vaccination schedule - 11PN-PD-DIT-010EUCTR2004-001823-39-SEGlaxoSmithKline Biologicals150
进行中（未招募）
1 期
An Investigational Study of Immunotherapy Combinations with Chemotherapy in Patients with Gastric or Gastroesophageal Junction (GEJ) CancersGastric or Gastroesophageal Junction AdenocarcinomaMedDRA version: 21.1Level: PTClassification code 10017758Term: Gastric cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 21.0Level: LLTClassification code 10056267Term: Gastroesophageal cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2018-001069-18-ATBristol-Myers Squibb International Corporation420
进行中（未招募）
1 期
An Investigational Study of Immunotherapy Combinations with Chemotherapy in Patients with Gastric or Gastroesophageal Junction (GEJ) CancersGastric or Gastroesophageal Junction AdenocarcinomaMedDRA version: 21.1Level: PTClassification code 10017758Term: Gastric cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 21.0Level: LLTClassification code 10056267Term: Gastroesophageal cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2018-001069-18-NOBristol-Myers Squibb International Corporation420
进行中（未招募）
1 期
An Investigational Study of Immunotherapy Combinations with Chemotherapy in Patients with Gastric or Gastroesophageal Junction (GEJ) CancersEUCTR2018-001069-18-DEBristol-Myers Squibb International Corporation420